share_log

聖諾醫藥-B:自願性公告 - Sirnaomics宣佈基於GalNAc RNAi療法藥物STP122G用於抗凝治療的I期臨床試驗第一序列圓滿完成

SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - SIRNAOMICS ANNOUNCES SUCCESSFUL COMPLETION OF COHORT 1 FROM PHASE I CLINICAL STUDY OF GALNAC-BASED RNAi THERAPEUTIC STP122G FOR ANTICOAGULANT TREATMENT

香港交易所 ·  Dec 5, 2023 09:21
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more